Multicenter, open-label, randomized controlled trial on Shenfu injection for shock

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001369

Enrollment

Unknown

Registered

2011-05-26

Start date

2011-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shock

Interventions

Control group:Saline 300ml intravenous injection for 6 days

Treatment group:Shenfu injection intravenous injection for 6 days, 100ml Shenfu injection diluted with 200ml saline per day

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Consistent with the diagnosis of shock; 2. age between 18 and 70.

Exclusion criteria

Exclusion criteria: 1. Poor prognosis, life expectancy < 24h; 2. With hypovolemic shock and require emergent surgery within 6h; 3. Give up medical resuscitation, failure to adhere to the systemic treatment (only for reasons from patients); 4. Allergic to drugs, food or medicine composition used in the trial; 5. Pregnant or lactating women; 6. Foreigners; 7. Participate in other clinical trials in the past 3 months ; 8. With other conditions that the researchers consider not fit this trial.

Design outcomes

Primary

Measure	Time frame
Lactate clearance;	—

Secondary

Measure	Time frame
Blood gas analysis;Inflammatory factor;Picc;	—

Countries

China

Contacts

Public ContactXuezhong YU

yxz@medmail.com.cn+86 10 65295301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026